TNF and lymphoma: However, because the blockade of TNF-α also plays a crucial role in modulating immune responses against B cell lymphomas, the long-term use of the agents raises concerns regarding the associated potential risk of developing lymphoma, a diverse group of malignancies arising from lymphocytes [5,6].